Schedule 13D ownership disclosure
VIRACTA THERAPEUTICS INC
Security class unavailable · CUSIP: 92765F108
Event date: 2021-02-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-21-000858
- Form type
- SC 13D
- Filer
- SUNESIS PHARMACEUTICALS INC
- CIK
- CIK 1061027
- Filed
- Mar 02, 2021
- Reporting period
- Feb 24, 2021
- Description
- Schedule 13D beneficial ownership